Study Evaluating the Performance and Safety in the Medium and Long Term of Global D Implant-prosthetic Systems
Launched by GLOBAL D · Jul 7, 2021
Trial Information
Current as of June 27, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is evaluating the safety and effectiveness of certain dental implants made by Global D, specifically the models In-Kone® UNIVERSAL, In-Kone® PRIMO, twinKon®, EVL® S, EVL® K, and EVL® C. The goal is to see how well these implants perform over time and ensure they are safe for patients. The study is currently looking for participants who have had one or more of these implants placed between 2013 and 2015 and are able to attend follow-up visits at specific intervals.
To be eligible, participants must be adults who received their implants during the specified time frame and are affiliated with French Social Security. They should have completed annual check-ups at 5, 7/8, and 10 years after their surgery. It’s important that participants understand the study and are willing to share their health data for research purposes. Those who are unable to understand the study details or have passed away since their implant surgery cannot take part. If you join this trial, you can expect to help researchers learn more about how these dental implants work in the long run.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Male or female
- • Major (s) at the time of the implantation
- * Having needed implant surgery with one or more Global D devices:
- • between October 1, 2013 - June 30, 2015 for EVL® S, EVL® K and EVL® C, In-Kone® UNIVERSAL and In-Kone® PRIMO implants
- • between January 1, 2013 - June 30, 2015 for twinKon® implants
- • Affiliated or benefiting from French Social Security
- • Not opposing the use of their data
- • Having carried out his annual follow-up visit at 5, 7/8 and 10 years or any other visit motivated by the removal of the implant during the 10 years
- Exclusion Criteria:
- • Patient unable to understand information related to his/her participation in the study
- • Deceased patient, date of death after the date of implantation
About Global D
Global D is a leading clinical trial sponsor dedicated to advancing medical research and innovation through robust clinical development programs. With a commitment to excellence, Global D collaborates with healthcare professionals, regulatory authorities, and industry partners to design and execute rigorous clinical trials across a diverse range of therapeutic areas. The organization prioritizes patient safety and adherence to ethical standards, leveraging cutting-edge technology and data analytics to optimize trial outcomes. Through its global reach and expertise, Global D aims to contribute significantly to the advancement of healthcare and improve patient outcomes worldwide.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Andrézieux Bouthéon, , France
Athens, , Greece
Patients applied
PS
CW
TN
Trial Officials
Jean Pierre AXIOTIS, MD
Principal Investigator
Dental surgeon
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials